E
En-Tang Kang
Researcher at National University of Singapore
Publications - 776
Citations - 41433
En-Tang Kang is an academic researcher from National University of Singapore. The author has contributed to research in topics: Polymerization & Surface modification. The author has an hindex of 97, co-authored 763 publications receiving 38498 citations. Previous affiliations of En-Tang Kang include University at Buffalo & Beijing University of Chemical Technology.
Papers
More filters
Journal ArticleDOI
Synthesis and characterization of new cardo polyamide‐imides containing ether and tricyclo[5.2.1.02, 6]decane groups
TL;DR: A new cardo diimide-dicarboxylic acid, 8,8-bis[4-trimellitimidophenoxy)phenyl]tricyclo-[5.1.2.
Journal ArticleDOI
A comparative study on the structural changes in leucoemeraldine and emeraldine base upon doping by perchlorate
TL;DR: In this paper, les interactions entre les atomes d'azote amino de la leucoemeraldine and les ions ClO 4 − donnent des structures nitrogenonium analogues a celles resultant de la protonation par HCl des atomes de la amino acid imino dans l'emeraldines, and la conductivite maximale dans ces composes atteint environ 4 S/cm.
Peer Review
Recent progress in tannic acid-driven antibacterial/antifouling surface coating strategies
TL;DR: In this paper , the authors address the recent advancements in the essential biomedical perspective of TA-based bioinspired universal surface coating technologies by focusing on their intrinsic features and ability to produce engineered functional composites.
Journal ArticleDOI
The use of thermal initiator to make organic bulk heterojunction solar cells with a good percolation path
TL;DR: In this article, a simple method is developed to make an interpenetrating network of poly(3-hexylthiophene-2,5-diyl) and fullerene (C60) by mixing P3HT solution with a thermal initiator 2,2′-azobis(isobutyronitrile) (AIBN).
Journal ArticleDOI
Designer tridentate mucin 1 aptamer for targeted drug delivery.
TL;DR: Results indicate that aptamer L3 has good potential for targeted drug therapeutics and was able to evade RAW 264.7 macrophages, resulting in an overall 5.5-fold increase of survivability of RAW cells as compared with when free DOX was used.